Haleon plc reports share capital and voting rights update

Published 01/05/2025, 15:36
Haleon plc reports share capital and voting rights update

Haleon plc (LSE/NYSE:HLN), a global leader in consumer health, has disclosed its total number of shares and voting rights as of April 30, 2025, in a recent filing with the Securities and Exchange Commission. The company reports a total of 9,020,990,697 ordinary shares, each with a nominal value of £0.01. Among these, 4,080,205 shares are held in treasury.

As a result, the total number of ordinary shares carrying voting rights in the company stands at 9,016,910,492. This figure is significant for shareholders and others with notification obligations, as it serves as the denominator for calculating changes in their interest in the company, according to the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

The statement, signed by Company Secretary Amanda Mellor on May 1, 2025, also reminds those with notifiable interests in Haleon to communicate such information to the company secretary via the provided email address.

Haleon is known for its commitment to delivering better everyday health with humanity. Its portfolio spans major categories such as Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements. The company prides itself on trusted brands like Advil, Sensodyne, Panadol, and Centrum, which are based on trusted science and a deep understanding of consumer needs.

For further company information, Haleon directs interested parties to its website. The filing ensures that Haleon maintains transparency regarding its capital structure and provides necessary information for regulatory compliance and shareholder communication. This update is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.